Corvus Pharmaceuticals (CRVS) Other Working Capital Changes (2015 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly Other Working Capital Changes came in at -$103000.0 in Q1 2026, down 432.26% year-on-year from $31000.0 in Q1 2025, and down 39.19% quarter-over-quarter from -$74000.0 in Q4 2025.
Corvus Pharmaceuticals (CRVS) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$103000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 432.26% year-over-year to -$103000.0 in Q1 2026; TTM through Mar 2026 was -$319000.0, a 382.3% decrease from a year earlier, with the FY2025 full-year figure at -$185000.0, up 26.59% from the prior year.
- Other Working Capital Changes eased to -$103000.0 in Q1 2026 per CRVS's latest filing, from -$74000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.3 million in Q3 2025 and bottomed at -$1.2 million in Q1 2025.
- The 5-year median for Other Working Capital Changes is $87000.0 (2025), against an average of $120823.5.
- Across the five-year window, Other Working Capital Changes jumped 109.28% in 2025 and slumped 432.26% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at $768000.0 in 2024, then slumped by 109.64% to -$74000.0 in 2025, then slumped by 39.19% to -$103000.0 in 2026.
- Per Business Quant, the three latest CRVS Other Working Capital Changes figures stand at -$103000.0 (Q1 2026), -$74000.0 (Q4 2025), and -$72000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | -1.17 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 223,000.00 |
| Sep 30, 2024 | 223,000.00 |